You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

trastuzumab

Showing 26 - 50 of 525
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

HER2 Positive Early Breast Cancer Trial in Shanghai (Docetaxel, carboplatin, Trastuzumab)

Recruiting
  • HER2 Positive Early Breast Cancer
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center Shanghai, China, 200032
Jun 6, 2023

HER2-positive Breast Cancer Trial in Tampa (biological, drug, procedure)

Recruiting
  • HER2-positive Breast Cancer
  • HER-2 pulsed DC1
  • +4 more
  • Tampa, Florida
    Moffitt Cancer Center
Oct 6, 2022

Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage IA Breast Cancer AJCC v8, Anatomic Stage IB Breast Cancer AJCC v8 Trial

Recruiting
  • Anatomic Stage I Breast Cancer AJCC v8
  • +19 more
  • pUMVC3-IGFBP2-HER2-IGF1R Plasmid DNA Vaccine
  • +3 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Aug 1, 2022

Esophageal Cancer, Esophageal Adenocarcinoma Trial in Amsterdam (Trastuzumab, Pertuzumab, Paclitaxel)

Recruiting
  • Esophageal Cancer
  • Esophageal Adenocarcinoma
  • Trastuzumab
  • +3 more
  • Amsterdam, Netherlands
    Academic Medical Center
Jun 18, 2022

Breast Cancer Trial (Tucatinib, Eribulin, Trastuzumab)

Not yet recruiting
  • Breast Cancer
  • (no location specified)
Jul 12, 2022

Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage IIA Breast Cancer AJCC v8, Anatomic Stage IIB Breast Cancer AJCC v8

Recruiting
  • Anatomic Stage II Breast Cancer AJCC v8
  • +19 more
  • Los Angeles, California
    UCLA / Jonsson Comprehensive Cancer Center
May 11, 2022

Breast Tumors Trial in Saint Louis (Doxorubicin, Trastuzumab, Cyclophosphamide)

Terminated
Has Results
  • Breast Neoplasms
  • Saint Louis, Missouri
    Washington University School of Medicine
Oct 31, 2022

HER2-positive Breast Cancer, HER2-positive Gastric Cancer, HER2-positive Metastatic Breast Cancer Trial in Germany, Spain,

Recruiting
  • HER2-positive Breast Cancer
  • +4 more
  • Essen, Germany
  • +5 more
Nov 15, 2022

Oncology, Infusion Reaction Trial (Nivolumab, Pembrolizumab, Ipilimumab)

Not yet recruiting
  • Oncology
  • Infusion Reaction
  • (no location specified)
Sep 8, 2023

Adenocarcinoma of the Rectum, Locally Advanced Rectal Adenocarcinoma, Rectal Adenocarcinoma Trial in United States (Trastuzumab,

Recruiting
  • Adenocarcinoma of the Rectum
  • +4 more
  • Basking Ridge, New Jersey
  • +6 more
Jan 3, 2023

HER2-positive Advanced Breast Cancer Trial (DP303c, Trastuzumab, Vinorelbine Tartrate)

Not yet recruiting
  • HER2-positive Advanced Breast Cancer
  • (no location specified)
Jun 4, 2023

HER2-positive Breast Cancer, Breast Adenocarcinoma, Stage II Breast Cancer AJCC v6 and v7 Trial in San Francisco (Neratinib,

Completed
  • HER2-positive Breast Cancer
  • +8 more
  • San Francisco, California
    University of California, San Francisco
Jan 6, 2023

Gastric Cancer Trial in Shanghai (HLX22, Placebo, Trastuzumab)

Recruiting
  • Gastric Cancer
  • Shanghai, China
    Shanghai East Hospital
Apr 24, 2022

Adenocarcinoma of the Stomach, Adenocarcinoma of Esophagogastric Junction, HER2-positive Gastric Cancer Trial in China

Not yet recruiting
  • Adenocarcinoma of the Stomach
  • +2 more
  • Hangzhou, Zhejiang, China
  • +7 more
Feb 7, 2023

First-line Treatment of HER2-positive Recurrent or Metastatic Breast Cancer Trial (KN026, HB1801, Pertuzumab)

Not yet recruiting
  • First-line Treatment of HER2-positive Recurrent or Metastatic Breast Cancer
  • (no location specified)
Apr 20, 2023

HER2 Positive Breast Cancer Trial in Ireland (Copanlisib, Trastuzumab)

Completed
  • HER2 Positive Breast Cancer
  • Cork, Ireland
  • +4 more
Jul 25, 2022

Breast Cancer, Cardiac Toxicity Trial in Rochester (biological, drug, genetic, other, procedure)

Completed
Has Results
  • Breast Cancer
  • Cardiac Toxicity
  • trastuzumab
  • +11 more
  • Rochester, Minnesota
    Mayo Clinic Cancer Research Consortium
Jul 12, 2022

HER2-positive Breast Cancer, LMD Trial (Tucatinib 150 MG, Trastuzumab, Capecitabine)

Not yet recruiting
  • HER2-positive Breast Cancer
  • LMD
  • Tucatinib 150 MG
  • +3 more
  • (no location specified)
Aug 24, 2023

Breast Cancer Trial in Boston, Ann Arbor (drug, procedure, radiation)

Active, not recruiting
Has Results
  • Breast Cancer
  • Trastuzumab
  • +6 more
  • Boston, Massachusetts
  • +2 more
May 2, 2022

Esophageal Squamous Cell Carcinoma, HER-2 Protein Overexpression, HER-2 Gene Amplification Trial in Copenhagen, Odense

Recruiting
  • Esophageal Squamous Cell Carcinoma
  • +2 more
  • Trastuzumab
  • Copenhagen, Region H, Denmark
  • +1 more
Aug 10, 2022

HER2-positive Breast Cancer Trial in Philadelphia (Atezolizumab, Paclitaxel, Trastuzumab)

Suspended
  • HER2-positive Breast Cancer
  • Philadelphia, Pennsylvania
    Fox Chase Cancer Center
Jul 5, 2022

Breast Tumors, Malignant Tumor of Breast Trial in Dallas (Trastuzumab, Ibrutinib 560 mg, Ibrutinib 840 mg)

Recruiting
  • Breast Neoplasms
  • Malignant Neoplasm of Breast
  • Trastuzumab
  • +3 more
  • Dallas, Texas
    10 sites incl TX, WA, VA, and NV
May 16, 2022

Metastatic Breast Cancer, HER2 Positive Breast Carcinoma Trial in United States (Niraparib, Trastuzumab)

Recruiting
  • Metastatic Breast Cancer
  • HER2 Positive Breast Carcinoma
  • Birmingham, Alabama
  • +6 more
Dec 13, 2022

Estrogen Receptor Negative, Estrogen Receptor Positive, HER2/Neu Negative Trial in Bellevue, Grand Island, Omaha (drug, other,

Active, not recruiting
  • Estrogen Receptor Negative
  • +15 more
  • Bellevue, Nebraska
  • +3 more
Nov 30, 2022

Carcinoma Breast Stage I, HER2 Positive Breast Cancer Trial in Mumbai (Trastuzumab, Placebo)

Recruiting
  • Carcinoma Breast Stage I
  • HER2 Positive Breast Cancer
  • Trastuzumab
  • Placebo
  • Mumbai, India
    Tata Memorial Centre
Apr 26, 2022